A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

H.M. Lokhorst; B. van der Holt; S Zweegman; E. Vellenga; S. Croockewit; M.H. Oers; P. von dem Borne; P. Wijermans; R. Schaafsma; O. de Weerdt; S. Wittebol; M. Delforge; H. Berenschot; G.M. Bos; K-S.G. Jie; H. Sinnige; M. van Marwijk-Kooy; P. Joosten; M.C. Minnema; R. van Ammerlaan; x HOVON Dutch-Belgian Hematology-Oncology Group; P. Sonneveld

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

Translated title of the contribution: A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

H.M. Lokhorst, B. van der Holt, S Zweegman, E. Vellenga, S. Croockewit, M.H. Oers, P. von dem Borne, P. Wijermans, R. Schaafsma, O. de Weerdt, S. Wittebol, M. Delforge, H. Berenschot, G.M. Bos, K-S.G. Jie, H. Sinnige, M. van Marwijk-Kooy, P. Joosten, M.C. Minnema, R. van Ammerlaanx HOVON Dutch-Belgian Hematology-Oncology Group, P. Sonneveld

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.
Original language	Undefined/Unknown
Pages (from-to)	1113-1120
Number of pages	8
Journal	Blood
Volume	115
Issue number	6
Publication status	Published - 2010

Cite this

Lokhorst, H. M., van der Holt, B., Zweegman, S., Vellenga, E., Croockewit, S., Oers, M. H., von dem Borne, P., Wijermans, P., Schaafsma, R., de Weerdt, O., Wittebol, S., Delforge, M., Berenschot, H., Bos, G. M., Jie, K.-SG., Sinnige, H., van Marwijk-Kooy, M., Joosten, P., Minnema, M. C., ... Sonneveld, P. (2010). A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma. Blood, 115(6), 1113-1120.

@article{e640855caf514a9ab87a81257ada1450,

title = "A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.",

author = "H.M. Lokhorst and {van der Holt}, B. and S Zweegman and E. Vellenga and S. Croockewit and M.H. Oers and {von dem Borne}, P. and P. Wijermans and R. Schaafsma and {de Weerdt}, O. and S. Wittebol and M. Delforge and H. Berenschot and G.M. Bos and K-S.G. Jie and H. Sinnige and {van Marwijk-Kooy}, M. and P. Joosten and M.C. Minnema and {van Ammerlaan}, R. and {HOVON Dutch-Belgian Hematology-Oncology Group}, x and P. Sonneveld",

year = "2010",

language = "Undefined/Unknown",

volume = "115",

pages = "1113--1120",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "6",

}

Lokhorst, HM, van der Holt, B, Zweegman, S, Vellenga, E, Croockewit, S, Oers, MH, von dem Borne, P, Wijermans, P, Schaafsma, R, de Weerdt, O, Wittebol, S, Delforge, M, Berenschot, H, Bos, GM, Jie, K-SG, Sinnige, H, van Marwijk-Kooy, M, Joosten, P, Minnema, MC, van Ammerlaan, R, HOVON Dutch-Belgian Hematology-Oncology Group, X & Sonneveld, P 2010, 'A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.', Blood, vol. 115, no. 6, pp. 1113-1120.

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma. / Lokhorst, H.M.; van der Holt, B.; Zweegman, S et al.
In: Blood, Vol. 115, No. 6, 2010, p. 1113-1120.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

AU - Lokhorst, H.M.

AU - van der Holt, B.

AU - Zweegman, S

AU - Vellenga, E.

AU - Croockewit, S.

AU - Oers, M.H.

AU - von dem Borne, P.

AU - Wijermans, P.

AU - Schaafsma, R.

AU - de Weerdt, O.

AU - Wittebol, S.

AU - Delforge, M.

AU - Berenschot, H.

AU - Bos, G.M.

AU - Jie, K-S.G.

AU - Sinnige, H.

AU - van Marwijk-Kooy, M.

AU - Joosten, P.

AU - Minnema, M.C.

AU - van Ammerlaan, R.

AU - HOVON Dutch-Belgian Hematology-Oncology Group, x

AU - Sonneveld, P.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0006-4971

VL - 115

SP - 1113

EP - 1120

JO - Blood

JF - Blood

IS - 6

ER -